BAJOKON LIMITID has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, pharmaceuticals and chemical engineering are CYANO BIOTECH GMBH, INST BIOTECHNOLOGII I ANTYBIOTYKÓW and JIANGSU YANCHENG YUANYAO BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 12 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Fermentation | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Chemical or physical processes | |
#6 | Heterocyclic compounds | |
#7 | Medical preparations | |
#8 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Ijer Kharish | 5 |
#2 | Patale Mukesh Babuappa | 4 |
#3 | Sambasivam Ganesh | 4 |
#4 | Tivari Sandzhaj | 4 |
#5 | Garg Saurabkh | 3 |
#6 | Kumar Bimal | 3 |
#7 | Dzhoshi Sulekkha | 3 |
#8 | Dave Nitesh | 3 |
#9 | Kumar Chittnalli Ramegovda Naveen | 3 |
#10 | Sridkharan Madkhavan | 3 |
Publication | Filing date | Title |
---|---|---|
RU2277090C9 | Method for preparing mycophenolic acid sodium salt representing immunosuppressant agent | |
RU2324676C2 | Form c of crystalline m-(trans-4-iso-propyl cyclohexil carbonyl)-b-phenylalanine for type 2 diabetes mellitus therapy and mode of obtaining it | |
RU2309141C2 | AMORPHOUS HMG-KoA REDUCTASE INHIBITORS AND A METHOD FOR PREPARATION THEREOF | |
RU2325393C2 | Boronic acid ester and production method |